[Seminar] Advancing Biologics Characterization by Mass Spectrometry

iBET, ITQB NOVA and SCIEX invite you to learn about the recent developments in analytical technologies for biopharmaceutical characterization.

Meet with the experts in Portugal to hear about the latest innovations in:

• Routine and advanced workflows for biopharmaceutical characterization
• Quantitation of new modalities
• SWATH workflows
• Host Cell Protein clearance

View detailed agenda with the guest speakers HERE and register HERE

10:00 Registration

10:15 Welcome Patricia Gomes-Alves, Lab Head Sanofi Satellite Lab,iBET

10:30 The Analytical Power of the QTOF Mass Spectrometry Platform to Assess Biologics Critical Quality Attributes Ricardo Gomes, Senior Research Associate, Mass Spectrometry Facility, iBET& ITQB

11:00 MAM solution by SCIEX Sean McCarthy, Senior Manager Global Markets, Biologics, SCIEX

11:30 Coffee Break

12:00 Probing Key Attributes of Biotherapeutics Susana Lobo, Senior Research Associate, Novartis Pharma Lab, iBET

12:30 Recapitulation of Human Neural Microenvironment Signatures in iPSC-derived NPC 3D Differentiation Daniel Simão,Senior Research Associate, iBET

13:00 Lunch (included in the registration)

14:00 Detection of a Reduced Monoclonal Antibody (mAb) at Low ng/ml Concentration in Biological Samples by CESI-MS Christopher Loessner, Applications Specialist CESI-MS, SCIEX

14:30 Novel Quantitative Methods for Biopharma Sean McCarthy, Senior Manager GlobalMarkets, Biologics, SCIEX

15:00 Coffee Break

15:30 BioZen. Fully Bio-inert Columns for Biologics Characterization and QC Testing Mandana Fasth, Business Development Manager Bioseparations Europe, Phenomenex

16:00 Absolute Quantification of Host Cell Protein by SWATH LC-MS/MS Towards Method Validation and Batch Release Testing Thomas Kofoed,CEO and Co-Founder, Alphalyse

16:30 Roundtable

17:00 End